NCT02396147 Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Participants Status COMPLETED Phase PHASE1
NCT02394834 An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02394795 Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRC Status COMPLETED Phase PHASE3
NCT02393378 Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate Status TERMINATED Phase PHASE2
NCT02389881 Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants Status COMPLETED Phase PHASE1
NCT02389816 A Phase 3 Study of Lu AA21004 in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT02388971 Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease Status WITHDRAWN Phase PHASE2
NCT02388737 Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive Esophagitis Status COMPLETED Phase PHASE3
NCT02388724 Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis Status COMPLETED Phase PHASE3
NCT02382640 Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release Capsule Status COMPLETED Phase PHASE1
NCT02381288 Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone Status TERMINATED Phase PHASE2
NCT02379091 Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE2
NCT02372097 A Phase 1, Bioequivalence Study of SYR-472 25mg and 50mg Tablets Status COMPLETED Phase PHASE1
NCT02371980 Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE4
NCT02370615 Drug-Drug Interaction Study Between TAK-272 and Itraconazole, Digoxin or Midazolam Status COMPLETED Phase PHASE1
NCT02370602 An [^11C]T-773 Positron Emission Tomography (PET) Study to Determine Phosphodiesterase10A Occupancy by TAK-063 Status COMPLETED Phase PHASE1
NCT02369796 A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism Status TERMINATED Phase PHASE2
NCT02367885 Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants Status COMPLETED Phase PHASE1/PHASE2
NCT02367872 Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Participants With Renal or Hepatic Impairment Status COMPLETED Phase PHASE1